Change in QTcF from baseline in the safety analysis set.
NONSUSTAINED VENTRICULAR TACHYCARDIA
Plot showing the least squares mean and 90% CIs based on a linear mixed-effects model at the indicated time points. AP30663 3 mg kgWith Holter monitoring, the most important ventricular finding was episodes of nonsustained ventricular tachycardia seen in both the active and placebo groups with the longest episodes being four beats (Extended Data Table No apparent effect of AP30663 was observed on laboratory parameters (Extended Data Table 